\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe European Commission (DG CNECT) has launched three surveys on future EU investment needs in the research, innovation and deployment of digital technologies and capabilities. The surveys are part of two ongoing studies, in preparation of the next Multiannual Financial Framework (2028-2034): one on the research, development and innovation of strategic digital technologies beyond 2027 and another on the deployment (integration, application and roll-out) of digital technologies and infrastructures and related skills development.
The surveys cover a broad range of digital technological areas, ranging from semiconductors and photonics to artificial intelligence, data, high performance computing and many others.
All surveys are open until 23 May 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
